Bortezomib (Apo) TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: bortezomib
Pack: Bortezomib (Apo) 3.5 mg powder for injection, 1 vial
Brand name
(ARTG)
: APO-Bortezomib bortezomib 3.5mg powder for injection vialWhat this medicine is used for
(ARTG)
Bortezomib, in combination with melphalan and prednisone is indicated for the treatment of patients with previously untreated multiple myeloma who are not candidates for high dose chemotherapy.,Bortezomib, as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma.,Bortezomib is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy and who have progressive disease.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Subcutaneous
- White to off-white powder
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Light
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient bortezomib
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
